OA09191A - Utilisation de certains interférons gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancer de l'ovaire par voie intrapéritonéale. - Google Patents

Utilisation de certains interférons gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancer de l'ovaire par voie intrapéritonéale.

Info

Publication number
OA09191A
OA09191A OA59732A OA59732A OA09191A OA 09191 A OA09191 A OA 09191A OA 59732 A OA59732 A OA 59732A OA 59732 A OA59732 A OA 59732A OA 09191 A OA09191 A OA 09191A
Authority
OA
OAPI
Prior art keywords
ovarian cancer
treatment
preparation
pharmaceutical compositions
compositions intended
Prior art date
Application number
OA59732A
Other languages
English (en)
French (fr)
Inventor
Brandely Maud
Lando Danielle
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA09191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of OA09191A publication Critical patent/OA09191A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59732A 1989-02-02 1990-02-02 Utilisation de certains interférons gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancer de l'ovaire par voie intrapéritonéale. OA09191A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901346A FR2644067B1 (fr) 1989-02-02 1989-02-02 Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale

Publications (1)

Publication Number Publication Date
OA09191A true OA09191A (fr) 1992-06-30

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59732A OA09191A (fr) 1989-02-02 1990-02-02 Utilisation de certains interférons gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancer de l'ovaire par voie intrapéritonéale.

Country Status (12)

Country Link
EP (1) EP0381584B1 (ko)
JP (1) JPH0772137B2 (ko)
KR (1) KR100203316B1 (ko)
AT (1) ATE99954T1 (ko)
AU (1) AU632528B2 (ko)
CA (1) CA2009106A1 (ko)
DE (1) DE69005837T2 (ko)
DK (1) DK0381584T3 (ko)
FR (1) FR2644067B1 (ko)
HU (1) HU204711B (ko)
OA (1) OA09191A (ko)
ZA (1) ZA90671B (ko)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療

Also Published As

Publication number Publication date
ZA90671B (en) 1991-04-24
FR2644067A1 (fr) 1990-09-14
JPH02235818A (ja) 1990-09-18
JPH0772137B2 (ja) 1995-08-02
EP0381584B1 (fr) 1994-01-12
HU900202D0 (en) 1990-03-28
HUT54302A (en) 1991-02-28
KR900012628A (ko) 1990-09-01
DE69005837T2 (de) 1994-05-11
KR100203316B1 (ko) 1999-06-15
FR2644067B1 (fr) 1993-02-05
AU632528B2 (en) 1993-01-07
AU4895390A (en) 1990-08-09
ATE99954T1 (de) 1994-01-15
CA2009106A1 (fr) 1990-08-02
DK0381584T3 (da) 1994-02-14
EP0381584A3 (fr) 1991-11-06
DE69005837D1 (de) 1994-02-24
HU204711B (en) 1992-02-28
EP0381584A2 (fr) 1990-08-08

Similar Documents

Publication Publication Date Title
IT1179635B (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea
FR2576791B1 (fr) Composition pharmaceutique a base d'erythropoietine humaine pour le traitement de l'anemie de tumeurs malignes
ATE311908T1 (de) Orale verabreichung von chemisch modifizierten proteinen
OA09317A (fr) "Utilisation d'un polypeptide ayant l'activité de l'interleukine 2 humaine pour la préparation de compositions pharmaceutiques destinées au traitement des leucémies".
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
FR2587216B1 (fr) Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie
DE68909267D1 (de) Medikament zur Behandlung von fibrotischer Störung und antifibrotische Verbindung.
FR2660863B1 (fr) Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement de cancers primitifs de la plevre.
DE69001686D1 (de) Behandlung von leukozytstoerungen mit gm-csf.
OA09191A (fr) Utilisation de certains interférons gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancer de l'ovaire par voie intrapéritonéale.
NO863027L (no) Peptidpreparater med kontinuerlig avgivelse.
ATE100717T1 (de) Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.
FR2589350B1 (fr) Tige pour le traitement dentaire par implantation dans l'os
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
BE904586A (fr) Urogastrone.
OA09469A (fr) Utilisation d'un polypeptide ayant l'activité de l'interféron gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancers primitifs de la plèvre.
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant
OA09530A (fr) Utilisation d'un polypeptide ayant l'activité de l'interleukine 2 humaine pour la préparation de compositions pharmaceutiques destinées au traitement des pneumothorax
FR2281757A1 (fr) Nouvelles compositions pharmaceutiques utiles au traitement de l'hypertension chez les animaux
FR2568124B1 (fr) Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
FR2598616B1 (fr) Composition pharmaceutique destinee au traitement des phenomenes d'inflammation chez les mammiferes
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
IT8847847A0 (it) Dispositivo per l'erogazione di ossigeno terapeutico composto e balsamico
ATE86499T1 (de) Vorbeugende massnahmen zur verhinderung der ''komplexen respiratorischen erkrankung bei rindern'' durch verabreichung von interferon.
IT1154631B (it) Sale metilglucamminico del flurbiprofen dotato di attivita' terapeutica e procedimento per la sua preparazione